Übersetzung für "Cardiac ischemia" in Deutsch

Overall, cardiovascular events reported were mainly of cardiac arrhythmias (including tachycardia), hypertension, cardiac arrests, ischemia, QT prolongation, with some reports of sudden death.

Icatibant has been shown to aggravate induced cardiac ischemia in several non-clinical models, although a detrimental effect has not consistently been shown in acute ischemia.

Currently, no definite conclusion can be drawn on the risk of cardiac ischemia (both Congestive Heart Failure and Myocardial ischaemia).

These effects of the Crataegus extract--in the following also called fraction (a)--allow to deduce a therapeutic application of Crataegus extracts in the prevention and treatment of short periods of cardiac ischemia (circulatory disturbances of the heart), reperfusion-caused cardiac lesions and sudden death due to cardiac arrest as well as other life-threatening reperfusion-caused pathological conditions.

These test results show that the maximum effects of fraction (a) against cardiac ischemia and reperfusion-induced lesions may only be obtained after long-term administration of fraction (a) and that a mere short-lasting but reliable protective effect can be expected after administration of 2×100 mg/kg of fraction (a) (1 day+1 hour before the ischemia).

Compounds of the invention are furthermore contemplated to be useful for the treatment of asthma, allergies, osteoarthritis and cardiac ischemia in mammals.

Hyperbaric oxygen therapy (HBOT) should be critically considered and initiated within six hours in patients with neurologic deficits, unconsciousness, cardiac ischemia, pregnancy, and/or a very high COHb concentration.

Albeit there is overwhelming evidence in the literature that BMCs ameliorate the effects of cardiac ischemia, it is not yet clear, whether any of the three potential BMC fates (neovascularization, transdifferentiation or paracrine effects) is the major driver of cardiac repair or whether all three routes contribute to the final outcome.

With the product Ginkgobil an original combination, standardized extract and ginkgo biloba-powder, for which I received a medal at the Geneva Motorshow, we successfully treated cardiac ischemia, sequelae of vascular accidents and arteriopatiile.

Furthermore, asthma bronchioles, COPD (chronic obstructive lung diseases), cardiac ischemia, as well as the peripheral arterial occlusive disease can be treated.

The present amides I can accordingly be used for the treatment of neurodegenerative diseases which occur after ischemia, trauma, subarachnoid hemorrhages and stroke, and of neurodegenerative diseases such as multiple infarct dementia, Alzheimer?s disease, Huntington?s disease and of epilepsies and furthermore for the treatment of damage to the heart after cardiac ischemia, reperfusion damage after vascular occlusion, damage to the kidneys after renal ischemia, skeletal muscle damage, muscular dystrophy, damage which occurs due to proliferation of the smooth muscle cells, coronary vasospasms, cerebral vasospasms, cataracts of the eyes, restenosis of the blood vessels after angioplasty.

Owing to the protective action of these substances in pathological hypoxic or ischaemic situations, further possible applications arise therefrom in surgical interventions for protection of organs with temporarily reduced supply, in organ transplants for protection of the removed organs, in angioplastic vascular or cardiac interventions, in ischemia of the nervous system, in the therapy of shock states and for the prevention of essential hypertonia.

The present 2-phenylbenzimidazoles and 2-phenylindoles of the general formula I can accordingly be used for the treatment and prophylaxis of neurodegenerative diseases which occur after ischemia, trauma (craniocerebral trauma), mass hemorrhages, subarachnoid hemorrhages and stroke, and of neurodegenerative diseases such as multiple infarct dementia, Alzheimer?s disease, Huntington?s disease and of epilepsies, in particular of generalized epileptic attacks, such as, for example, petit mal and tonic-clonic attacks and partial epileptic attacks, such as temporal lobe and complex partial attacks, and furthermore for the treatment and prophylaxis of damage to the heart after cardiac ischemia and damage to the kidneys after renal ischemia, for example of acute renal insufficiency, of acute kidney failure or of damage which occurs during and after a kidney transplant.

The present 2-phenylbenzimidazoles of the general formula I can accordingly be used for the treatment and prophylaxis of neurodegenerative diseases occurring after ischemia, trauma (craniocerebral trauma), massive bleeding, subarachnoid hemorrhages and stroke, and of neurodegenerative diseases such as multi-infarct dementia, Alzheimer's disease, Huntington's disease and of epilepsies, in particular of generalized epileptic seizures, such as, for example, petit mal and tonoclonic seizures and partial epileptic seizures such as temporal lope, and complex partial seizures, and further for the treatment and prophylaxis of damage to the heart after cardiac ischemia and damage to the kidneys after renal ischemia, for example of acute renal insufficiency, of acute kidney failure or of damage occurring during and after a kidney transplant.

The new Collaborative Research Centre "Master Switches in Cardiac Ischemia" intends to analyse in greater detail the phase following an AMI through experimental pre-clinical investigations on small and large animal models and clinical investigations.

These drugs have a positive effect on the cardiovascular system, are virtually devoid of side effects and actually reduce the risk of stroke, reduce cardiac ischemia.

Soon, I was taken to Wanjia Forced Labour Camp, but the officials refused to accept me because a physical exam revealed I had severe cardiac arrhythmias and ischemia.

The compounds of the formula I and their physiologically acceptable salts are valuable therapeutics which are suitable for use on humans or mammals not only as antiarrhythmics but also for the treatment and prophylaxis in other disturbances of the cardiovascular system, for cardiac insufficiency, ischemias or heart transplants, or for cerebral vascular diseases.

Also classified within this area, in a broader sense, are, for example, transient cardiac ischemias: so-called silent myocardial ischemic episodes which are not noticed by the patient but can be seen in the EKG.

The compounds of the formula I and their physiologically tolerable salts are valuable therapeutics, which are suitable for use in humans and animals not only as antiarrhythmics and for the control and prevention of the sequelae of arrhythmias, but also for treatment and prophylaxis in other disorders of the cardiovascular system, for example cardiac insufficiency, ischemias or heart transplantation, or in cerebral vascular disorders.

Accordingly, the present amides I can be used for treating neurodegenerative diseases which occur following ischemia, trauma, subarachnoidal hemorrhages and stroke, and for treating neurodegenerative diseases such as multiple infarction dementia, Alzheimer?s disease and Huntington?s disease, and for treating epilepsies, and, furthermore, for treating damage to the heart following cardiac ischemias, damage to the kidneys following renal ischemias, skeletal muscle damage, muscular dystrophies, damage which arises due to proliferation of the smooth muscle cells, coronary vasospasms, cerebral vasospasms, cataracts of the eyes and restenosis of the blood vessels following angioplasty.

On this background, HBOT should be the method of choice in adult patients with neurological deficits, cardiac ischemias, loss of consciousness, metabolic acidosis, and COHb values > 25%.